Cargando…

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

Detalles Bibliográficos
Autores principales: Lee, Seung-Hoon, Jeon, Sang Won, Shin, Cheolmin, Pae, Chi-Un, Patkar, Ashwin A., Masand, Prakash S., An, Hyonggin, Han, Changsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233947/
https://www.ncbi.nlm.nih.gov/pubmed/35753689
http://dx.doi.org/10.30773/pi.2021.0368e
_version_ 1784735922972000256
author Lee, Seung-Hoon
Jeon, Sang Won
Shin, Cheolmin
Pae, Chi-Un
Patkar, Ashwin A.
Masand, Prakash S.
An, Hyonggin
Han, Changsu
author_facet Lee, Seung-Hoon
Jeon, Sang Won
Shin, Cheolmin
Pae, Chi-Un
Patkar, Ashwin A.
Masand, Prakash S.
An, Hyonggin
Han, Changsu
author_sort Lee, Seung-Hoon
collection PubMed
description
format Online
Article
Text
id pubmed-9233947
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Neuropsychiatric Association
record_format MEDLINE/PubMed
spelling pubmed-92339472022-07-08 Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study Lee, Seung-Hoon Jeon, Sang Won Shin, Cheolmin Pae, Chi-Un Patkar, Ashwin A. Masand, Prakash S. An, Hyonggin Han, Changsu Psychiatry Investig Erratum Korean Neuropsychiatric Association 2022-06 2022-06-15 /pmc/articles/PMC9233947/ /pubmed/35753689 http://dx.doi.org/10.30773/pi.2021.0368e Text en Copyright © 2022 Korean Neuropsychiatric Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Erratum
Lee, Seung-Hoon
Jeon, Sang Won
Shin, Cheolmin
Pae, Chi-Un
Patkar, Ashwin A.
Masand, Prakash S.
An, Hyonggin
Han, Changsu
Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
title Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
title_full Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
title_fullStr Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
title_full_unstemmed Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
title_short Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
title_sort acute efficacy and safety of escitalopram versus desvenlafaxine and vortioxetine in the treatment of depression with cognitive complaint: a rater-blinded randomized comparative study
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233947/
https://www.ncbi.nlm.nih.gov/pubmed/35753689
http://dx.doi.org/10.30773/pi.2021.0368e
work_keys_str_mv AT leeseunghoon acuteefficacyandsafetyofescitalopramversusdesvenlafaxineandvortioxetineinthetreatmentofdepressionwithcognitivecomplaintaraterblindedrandomizedcomparativestudy
AT jeonsangwon acuteefficacyandsafetyofescitalopramversusdesvenlafaxineandvortioxetineinthetreatmentofdepressionwithcognitivecomplaintaraterblindedrandomizedcomparativestudy
AT shincheolmin acuteefficacyandsafetyofescitalopramversusdesvenlafaxineandvortioxetineinthetreatmentofdepressionwithcognitivecomplaintaraterblindedrandomizedcomparativestudy
AT paechiun acuteefficacyandsafetyofescitalopramversusdesvenlafaxineandvortioxetineinthetreatmentofdepressionwithcognitivecomplaintaraterblindedrandomizedcomparativestudy
AT patkarashwina acuteefficacyandsafetyofescitalopramversusdesvenlafaxineandvortioxetineinthetreatmentofdepressionwithcognitivecomplaintaraterblindedrandomizedcomparativestudy
AT masandprakashs acuteefficacyandsafetyofescitalopramversusdesvenlafaxineandvortioxetineinthetreatmentofdepressionwithcognitivecomplaintaraterblindedrandomizedcomparativestudy
AT anhyonggin acuteefficacyandsafetyofescitalopramversusdesvenlafaxineandvortioxetineinthetreatmentofdepressionwithcognitivecomplaintaraterblindedrandomizedcomparativestudy
AT hanchangsu acuteefficacyandsafetyofescitalopramversusdesvenlafaxineandvortioxetineinthetreatmentofdepressionwithcognitivecomplaintaraterblindedrandomizedcomparativestudy